Abolfazl Olyaei | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Forensic Scientist Awards

Best Researcher Award

Abolfazl Olyaei
Imam Khomeini International University Faculty of Science, Iran
Abolfazl Olyaei
Affiliation Imam Khomeini International University Faculty of Science
Country Iran
Scopus ID 14009290900
Documents 94
Citations 1,047
h-index 18
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Forensic Scientist Awards
ORCID 0000-0003-2976-9481

The Best Researcher Award recognizes sustained scholarly achievement and measurable scientific impact within a specialized discipline. This article summarizes the academic profile of Abolfazl Olyaei, whose research activities focus on heterocyclic chemistry, green synthetic methodologies, medicinal chemistry, and pharmaceutical sciences. The information presented is based on publicly available scholarly records, publication metadata, citation indicators, and institutional affiliations.[1]

Abstract

Abolfazl Olyaei has established a consistent research portfolio in synthetic organic chemistry with emphasis on environmentally friendly reaction pathways, heterocyclic compounds, and biologically active molecular frameworks. His publication record demonstrates continuing contributions toward sustainable synthetic methodologies and pharmaceutical chemistry, supported by strong citation performance and international journal publications.[2]

Keywords

Green Chemistry, Heterocyclic Synthesis, Pharmaceutical Science, Organic Chemistry, Medicinal Chemistry, Catalysis, Sustainable Synthesis, Toxicology.

Introduction

Modern pharmaceutical research increasingly emphasizes sustainable chemical synthesis and efficient production of biologically relevant compounds. Dr. Olyaei’s investigations contribute to these objectives by exploring one-pot multicomponent reactions, environmentally benign solvents, and innovative heterocyclic scaffolds applicable to medicinal chemistry.[3]

Research Profile

According to indexed scholarly databases, the researcher has produced 94 publications with more than one thousand citations and an h-index of 18. His academic work spans pharmacology, toxicology, pharmaceutical science, and advanced organic synthesis. Collaborative publications appear in internationally recognized journals including RSC Advances and ChemistrySelect.[1]

Research Contributions

  • Development of green multicomponent synthetic methodologies.
  • Investigation of heterocyclic compounds with pharmaceutical relevance.
  • Promotion of aqueous and environmentally friendly reaction media.
  • Review articles summarizing biologically active molecular frameworks.

Publications

  • Aqueous glyoxal: a versatile synthon in heterocyclic synthesis. RSC Advances (2026).
  • Regioselective green synthesis of indole-substituted benzo[f]chromenes. RSC Advances (2026).
  • Sequential Tandem Four-Component Reaction. ChemistrySelect (2025).
  • Review on synthesis of furonaphthoquinones. RSC Advances (2025).
  • Acid-Mediated One-Pot Three-Component Tandem Cyclization. ChemistrySelect (2024).

Research Impact

The citation profile and publication output indicate sustained scholarly influence in synthetic and medicinal chemistry. Research themes emphasize reproducibility, environmentally responsible synthesis, and development of biologically relevant compounds, reflecting continued engagement with internationally recognized scientific challenges.[4]

Award Suitability

Based on documented publication productivity, citation performance, peer-reviewed contributions, and relevance to pharmaceutical and forensic sciences, the academic profile demonstrates characteristics commonly considered during international research award evaluations. This assessment reflects publicly available scholarly evidence rather than endorsement.[5]

Conclusion

Abolfazl Olyaei has developed a noteworthy academic record through sustained publication, interdisciplinary collaboration, and contributions to green synthetic chemistry. His research continues to support advances in pharmaceutical science and heterocyclic chemistry while maintaining international scholarly visibility through indexed publications and measurable citation impact.

External Links

References

  1. Elsevier. Scopus Author Details: Abolfazl Olyaei, Author ID 14009290900.
    https://www.scopus.com/authid/detail.uri?authorId=14009290900
  2. ORCID. Researcher Profile.
    https://orcid.org/0000-0003-2976-9481
  3. RSC Advances. Aqueous glyoxal: a versatile synthon in heterocyclic synthesis.
    https://doi.org/10.1039/D5RA08496B
  4. ChemistrySelect. Sequential Tandem Four-Component Reaction.
    https://doi.org/10.1002/slct.202505685
  5. International Forensic Scientist Awards. Official Award Website.
    forensicscientist.org

Shivani Chib | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Published on by Forensic Scientist Awards

Ms. Shivani Chib | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Central University of Punjab | India

Ms. Shivani Chib is an emerging researcher in the field of pharmacology, specializing in neurodegenerative diseases with a particular focus on Parkinson’s disease and the therapeutic potential of phytoconstituents. Currently pursuing her Ph.D. at the Central University of Punjab, Bathinda, she has contributed extensively through high-impact publications, innovative patents, international presentations, and active peer-reviewing for reputed journals. With multiple national and international awards, she stands out as a dedicated woman researcher committed to advancing pharmacological science and drug discovery.

Professional Profile

Scopus

Google Scholar

Education

Ms. Shivani Chib is currently pursuing her doctoral research in Pharmacology at the Central University of Punjab, Bathinda, under the guidance of Dr. Randhir Singh. Her Ph.D. research centers on Parkinson’s disease and the therapeutic potential of bioactive phytoconstituents, reflecting her dedication to translational research in neuropharmacology. Before her doctoral studies, she completed her Master of Pharmacy in Pharmacology from ISF College of Pharmacy, where she excelled academically and carried out research in experimental pharmacology. Her academic journey began with a Bachelor of Pharmacy in Pharmaceutical Sciences from Sri Sai College of Pharmacy. This progression in higher education reflects not only her intellectual growth but also her determination to specialize in pharmacology and contribute to the field of neuroscience.

Experience

Her professional journey as a researcher began during her postgraduate studies, where she worked as a Research Scholar and focused on understanding drug mechanisms and neuroprotective agents. Currently, as a Ph.D. Research Scholar at the Central University of Punjab, she is engaged in cutting-edge research on Parkinson’s disease, with particular emphasis on dopaminergic neuronal death and the role of phytochemicals such as luteolin and wogonin. She has also contributed as a reviewer for multiple Springer Nature journals, a role that reflects her expertise and recognition in the scientific community. Her active engagement in national and international conferences, combined with her innovative experimental approaches, illustrates her wide-ranging experience in both research and academic settings.

Research Interest

Her research interests revolve around neuropharmacology, neurodegenerative disorders, natural product-based drug discovery, and cognitive impairments associated with aging. She has a deep focus on elucidating the mechanisms of dopaminergic neuronal death in Parkinson’s disease and identifying bioactive phytoconstituents like luteolin and wogonin as potential therapeutic agents. Additionally, her work extends to exploring CNS toxicity of chemotherapeutics, marine functional foods, metabolic syndromes, and the cross-talk between central nervous and cardiovascular systems.

Awards and Recognitions

Ms. Shivani Chib has received numerous awards and recognitions throughout her career, including Best Working Model Award, Best Poster Awards at national and international conferences, and the prestigious GPAT fellowship. She has been awarded multiple international travel grants, including from the Movement Disorder Society and the Anusandhan National Research Foundation, enabling her to present her work globally, including at conferences in the USA and Japan. She has also received certificates of excellence in peer reviewing from Springer Nature and BP International. Her innovation in neuroscience is further highlighted by her registered patents on novel laboratory apparatuses, reflecting her inventive approach to experimental pharmacology.

Publications

Ms. Shivani Chib has published widely in reputed international journals, with her contributions cited in several scholarly works. Selected publications include:

Title: Unveiling the interplay of AMPK/SIRT1/PGC-1α axis in brain health: Promising targets against aging and NDDs
Journal: Ageing Research Reviews
Published on: 2024
Citation: 49

Title: Manganese and related neurotoxic pathways: A potential therapeutic target in neurodegenerative diseases
Journal: Neurotoxicology and Teratology
Published on: 2022
Citation: 35

Title: Unlocking the therapeutic potential of natural stilbene: exploring pterostilbene as a powerful ally against aging and cognitive decline
Journal: Ageing Research Reviews
Published on: 2023
Citation: 21

Title: Treatment of diabetic complications: do flavonoids holds the keys?
Journal: Critical Reviews in Food Science and Nutrition
Published on: 2024
Citation: 16

Title: Paradigms and success stories of natural products in drug discovery against neurodegenerative disorders (NDDs)
Journal: Current Neuropharmacology
Published on: 2024
Citation: 15

Title: Microbiota-brain-gut-Axis relevance to Parkinson’s disease: potential therapeutic effects of probiotics
Journal: Current Pharmaceutical Design
Published on: 2022
Citation: 11

Title: Role of flavonoids in mitigating the pathological complexities and treatment hurdles in Alzheimer’s disease
Journal: Phytotherapy Research
Published on: 2025
Citation: 10

Conclusion

Ms. Shivani Chib has established herself as a promising woman researcher in pharmacology through her strong academic background, impactful publications, innovative patents, and global recognitions. Her work in exploring the therapeutic applications of phytoconstituents against neurodegenerative disorders has the potential to open new pathways for safer and more effective treatments. With her commitment to excellence, interdisciplinary approach, and growing global presence, she exemplifies the qualities of a future leader in pharmacological sciences. She is therefore highly deserving of the Women Researcher Award, which would further empower her to continue contributing to scientific progress and global healthcare solutions.